Search

Author/Creator Lockhart, A Craig

2. Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22–05): a single-arm, phase 1b–2 trial. Issue 8 (August 2020)

Authors:
Catenacci, Daniel V T; Kang, Yoon-Koo; Park, Haeseong; Uronis, Hope E; Lee, Keun-Wook; Ng, Matthew C H; Enzinger, Peter C; Park, Se Hoon; Gold, Philip J; Lacy, Jill; Hochster, Howard S; Oh, Sang Cheul; Kim, Yeul Hong; Marrone, Kristen A; Kelly, Ronan J; Juergens, Rosalyn A; Kim, Jong Gwang; Bende...
Journal:
Lancet oncology
Issue:
Volume 21:Issue 8(2020)
Page Start:
1066
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Safety and activity of alisertib, an investigational aurora kinase A inhibitor, in patients with breast cancer, small-cell lung cancer, non-small-cell lung cancer, head and neck squamous-cell carcinoma, and gastro-oesophageal adenocarcinoma: a five-arm phase 2 study. Issue 4 (April 2015)

Authors:
Melichar, Bohuslav; Adenis, Antoine; Lockhart, A Craig; Bennouna, Jaafar; Dees, E Claire; Kayaleh, Omar; Obermannova, Radka; DeMichele, Angela; Zatloukal, Petr; Zhang, Bin; Ullmann, Claudio Dansky; Schusterbauer, Claudia
Journal:
Lancet oncology
Issue:
Volume 16:Issue 4(2015:Apr.)
Page Start:
395
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Safety and activity of alisertib, an investigational aurora kinase A inhibitor, in patients with breast cancer, small-cell lung cancer, non-small-cell lung cancer, head and neck squamous-cell carcinoma, and gastro-oesophageal adenocarcinoma: a five-arm phase 2 study. Issue 4 (April 2015)

Authors:
Melichar, Bohuslav; Adenis, Antoine; Lockhart, A Craig; Bennouna, Jaafar; Dees, E Claire; Kayaleh, Omar; Obermannova, Radka; DeMichele, Angela; Zatloukal, Petr; Zhang, Bin; Ullmann, Claudio Dansky; Schusterbauer, Claudia
Journal:
Lancet oncology
Issue:
Volume 16:Issue 4(2015:Apr.)
Page Start:
395
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial. Issue 5 (May 2016)

Authors:
Nywening, Timothy M; Wang-Gillam, Andrea; Sanford, Dominic E; Belt, Brian A; Panni, Roheena Z; Cusworth, Brian M; Toriola, Adetunji T; Nieman, Rebecca K; Worley, Lori A; Yano, Motoyo; Fowler, Kathryn J; Lockhart, A Craig; Suresh, Rama; Tan, Benjamin R; Lim, Kian-Huat; Fields, Ryan C; Strasberg, S...
Journal:
Lancet oncology
Issue:
Volume 17:Issue 5(2016:May)
Page Start:
651
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗